Forum Merger II, filed their CERT just before the market close today, indicating they will be pricing their IPO tonight for trading Friday.
This is Jefferies’ first 2018 SPAC as sole bookrunning manager, and a $200 million deal is a nice way to start. Additionally, EarlyBirdCapital is in the co-manager position.
The $200 million Forum Merger II has a broad search mandate, but they state they intend to focus on companies with an enterprise value between $500 million and $2 billion and are located in the U.S.
Summary of terms located below:
- Sector Focus: EV between $500mm and $2bn, located in the U.S.
- $10.00 unit comprised of one share Class A Common Stock, one redeemable Warrant
- 100% held in trust ($10.00 per share)
- 18 months to complete an acquisition
- Limitation on redemption rights of stockholders: 15%
- Warrant call for redemption price: $18.00
- Underwriter fees: 2.0% + 3.5% deferred fee. Jefferies is sole bookrunner, EarlyBird Capital is co-manager.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...